PriestleyJ. Experiments and observations on different kinds of air, volume II. London: J. Johnson; 1775.
2.
SoRelleR. Nobel prize awarded to scientists for nitric oxide discoveries. Circulation, 1998; 98(22):2365–2366.
3.
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med, 1997; 336(9):597–604.
4.
LinYJ, MarkhamNE, BalasubramaniamV, TangJR, MaxeyA, KinsellaJP, AbmanSH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res, 2005; 58(1):22–29.
5.
BallardPL, GonzalesLW, GodinezRI, GodinezMH, SavaniRC, McCurninDC, et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res, 2006; 59(1):157–162.
6.
BlandRD, AlbertineKH, CarltonDP, MacRitchieAJ. Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs. Am J Respir Crit Care Med, 2005; 172(7):899–906.
7.
TangJR, MarkhamNE, LinYJ, McMurtryIF, MaxeyA, KinsellaJP, AbmanSH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol, 2004; 287(2):L344–L351.
8.
ColeFS, AlleyneC, BarksJD, BoyleRJ, CarrollJL, DokkenD, et al. NIH Consensus Development Conference statement: inhaled nitric-oxide therapy for premature infants. Pediatrics, 2011; 127(2):363–369.
9.
JensenEA, KirpalaniH. Inhaled nitric oxide to prevent bronchopulmonary dysplasia in preterm infants–less than a silver bullet. J Pediatr, 2014; 165(6):1079–1081.
10.
AfshariA, BrokJ, MøllerAM, WetterslevJ. Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg, 2011; 112(6):1411–1421.
11.
ChecchiaPA, BronickiRA, GoldsteinB. Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Cardiol, 2012; 33(4):493–505.
12.
KawakamiH, IchinoseF. Inhaled nitric oxide in pediatric cardiac surgery. Int Anesthesiol Clin, 2004; 42(4):93–100.
13.
IchinoseF, RobertsJDJr, ZapolWM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation, 2004; 109(25):3106–3111.
14.
SimsicJM, HarrisonS, EvansL, McCleadR, TeskeD, Institute of Healthcare Improvement. Reducing variation in the use of inhaled nitric oxide. Pediatrics, 2014; 133(6):e1753–e1758.
15.
Todd TzanetosDR, HousleyJJ, BarrFE, MayWL, LandersCD. Implementation of an inhaled nitric oxide protocol decreases direct cost associated with its use. Respir Care, 2015; 60(5):644–650.
16.
BergM. Problems and promises of the protocol. Soc Sci Med, 1997; 44(8):1081–1088.
17.
MaselliDJ, FernandezJF. Can respiratory therapist-driven protocols improve resource utilization?. Respir Care, 2013; 58(3):546–547.
18.
ChatburnRL, DeemS. Respiratory controversies in the critical care setting. Should weaning protocols be used with all patients who receive mechanical ventilation? Respir Care, 2007; 52(5):609–619; discussion 619-621.
19.
StollerJK. The effectiveness of respiratory care protocols. Respir Care, 2004; 49(7):761–765.
20.
KollefMH, ShapiroSD, ClinkscaleD, CracchioloL, ClaytonD, WilnerR, HossinL. The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. Chest, 2000; 117(2):467–475.
21.
StollerJK, KesterL. Respiratory care protocols in postanesthesia care. J Perianesth Nurs, 1998; 13(6):349–358.
22.
ZimmermanL. Respiratory therapist-driven protocols. West J Med, 1997; 167(6):440–441.
23.
StollerJK. Respiratory therapist-driven protocols. Rationale and efficacy. West J Med, 1997; 167(6):408–410.
24.
BurtonGG. A short history of therapist-driven respiratory care protocols. Respir Care Clin N Am, 1996; 2(1):15–26.
25.
SiobalMS, HessDR. Are inhaled vasodilators useful in acute lung injury and acute respiratory distress syndrome?. Respir Care, 2010; 55(2):144–157; discussion 157-161.
26.
SiobalMS. Pulmonary vasodilators. Respir Care, 2007; 52(7):885–899.
27.
SiobalM. Aerosolized prostacyclins. Respir Care, 2004; 49(6):640–652.
28.
DownarJ, YouJJ, BagshawSM, GolanE, LamontagneF, BurnsK, et al. Nonbeneficial treatment Canada: definitions, causes, and potential solutions from the perspective of healthcare practitioners. Critical Care Med, 2015; 43(2):270–281.